Management of Hypertension in Diabetic Pregnancy

Guideline-Based Recommendations

The American Diabetes Association recommends labetalol as a safe and effective antihypertensive in pregnancy for pregnant women with diabetes and hypertension 1, 2, 3, 4
The American Diabetes Association suggests that other beta blockers may be used if necessary, with the notable exception of atenolol, which is not recommended due to documented associations with lower birth weight and fetal growth restriction 1, 2, 3, 4
The American College of Obstetricians and Gynecologists recommends avoiding atenolol during pregnancy due to its association with fetal growth restriction and lower birth weight 1, 2, 3, 4, 5

The American Heart Association recommends the following first-line options for hypertension management in diabetic pregnancy: methyldopa, long-acting nifedipine, and labetalol 1, 2, 3, 4, 5
The American College of Cardiology suggests that diltiazem, clonidine, and prazosin are also safe options for hypertension management in diabetic pregnancy 1, 2, 3, 4
The American Diabetes Association recommends avoiding atenolol, ACE inhibitors, angiotensin receptor blockers, and chronic diuretics due to their potential harmful effects on the fetus 1, 2, 3, 4, 5

The American College of Obstetricians and Gynecologists recommends targeting a blood pressure of 110-135/85 mmHg in pregnant diabetic patients with chronic hypertension to balance maternal hypertension risk against fetal growth impairment 1, 2, 3, 4, 5
The American Diabetes Association suggests that insulin remains the preferred treatment for diabetes itself during pregnancy, not beta blockers for glycemic control 2